Jonathan Goodman, MPhil

Oncology Editor

Jonathan was the editor of Cancer Therapy Advisor from 2016 to 2018. His work has appeared in Aeon Magazine, The Week, and The Guardian, among other publications.

Most Recent Articles by Jonathan Goodman, MPhil

FDA Grants Orphan Drug Designation to BN-Brachyury for Chordoma

FDA Grants Orphan Drug Designation to BN-Brachyury for Chordoma

By

Researchers plan to initiate a phase 2 trial of the vaccine, which will enroll up to 25 patients with metastatic chordoma.

Online Survey May Allow Patients With Prostate Cancer To Accurately Report Comorbidities

Online Survey May Allow Patients With Prostate Cancer To Accurately Report Comorbidities

By

The BMH online survey allows patients to enter comorbidity data at home prior to consultation.

Physical Activity Monitors May Accurately Predict Patient Performance Status

Physical Activity Monitors May Accurately Predict Patient Performance Status

By

At study completion, 75% of surveyed patients reported a positive experience with the PAM.

Non-Drug Costs of CAR-T Cell Therapy May Exceed $50,000

Non-Drug Costs of CAR-T Cell Therapy May Exceed $50,000

By

Researchers noted that while non-drug costs account for only 7% of CAR-T therapy-related expenses, these costs may range from $30,000 to $56,000.

Hormone Therapy for Breast Cancer May Cause Diabetes

Hormone Therapy for Breast Cancer May Cause Diabetes

By

It was unknown whether breast cancer treatment plays a causal role in the onset of diabetes.

More Articles by Jonathan Goodman, MPhil

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs